Akorn reviews record consolidated revenue of $73.9 million in first quarter 2013 Akorn, Inc http://suhagrastore.com/faq . , a niche generic pharmaceutical company, today reported financial results for its first quarter ended March 31, 2013. Raj Rai, CEO, commented, ‘We are happy with our first quarter results although we had been behind in the launches of certain products which were approved late this past year because of capacity constraints with this contract manufacturing partners along with market challenges. We expect resolution sometime in the second half of the year. We are also worked up about the establishment of our brand-new R&D center in Vernon Hills, Illinois.